Format

Send to

Choose Destination
Neonatal Netw. 2013 Jul-Aug;32(4):274-80. doi: 10.1891/0730-0832.32.4.274.

Skin-to-skin contact diminishes pain from hepatitis B vaccine injection in healthy full-term neonates.

Author information

1
Cleveland State University, USA. rrkostandy@yahoo.com

Abstract

PURPOSE:

This study was conducted to test the hypothesis that skin-to-skin contact (SSC) would reduce hepatitis B vaccine injection pain in full-term neonates.

DESIGN:

Randomized controlled trial (RCT).

SAMPLE:

Thirty-six mother-;neonate dyads were randomly assigned to SSC or control groups.

MAIN OUTCOMES:

Cry time (CT ), behavioral state (BSt), and heart rate (HR ) were measured throughout the 16-minute protocol. HR and BSt were measured every 30 seconds; CT was recorded continuously.

RESULTS:

SSC neonates cried less compared with controls (23 vs 32 seconds during injection; 16 vs 72 seconds during recovery), reached calmer BSts sooner (M = 2.8 vs M = 6.5 time points), and trended toward more rapid HR decrease. SSC as described was safe and effective and merits further testing.

PMID:
23835546
DOI:
10.1891/0730-0832.32.4.274
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center